There are 2789 resources available
853P - PRAME expression and ImmTAC TCR bispecific sensitivity in acute myeloid leukaemia in the presence and absence of the hypomethylating agent decitabine
Presenter: Camille Britton-Rivet
Session: ePoster Display
854P - Final results of a phase II study of tipifarnib in chronic myelomonocytic leukemia (CMML) and other myelodysplastic/myeloproliferative neoplasms (MDS/MPN)
Presenter: Mrinal Patnaik
Session: ePoster Display
855P - Exploring the cardio-cerebrovascular outcomes and thromboembolic risks among BCR-ABL1-negative myeloproliferative neoplasms treated with ruxolitinib: Systematic review and meta-analysis
Presenter: Boby Pratama Putra
Session: ePoster Display
856P - A comparison of the burden of leukemia amongst European Union 15+ countries, 1990-2019
Presenter: Chinmay Jani
Session: ePoster Display
892P - The genomic features of Chinese oropharyngeal squamous cell carcinomas and the implications for therapy
Presenter: QUNXING LI
Session: ePoster Display
893P - Clinico-genetic profiling of HRAS mutant head and neck squamous cell carcinoma (HNSCC)
Presenter: Xiuning Le
Session: ePoster Display
894P - Investigation of ARID1A mutation and correlation with immunotherapy biomarker in Chinese head and neck cancer patients
Presenter: Jianming gao
Session: ePoster Display
895P - Disproportional enrichment of FoxP3+CD4+ regulatory T-cells shapes a suppressive tumor microenvironment and provokes anti–PD-1 resistance in head and neck squamous cell carcinoma
Presenter: Chang Gon Kim
Session: ePoster Display